PDCD1LG2 and head and neck squamous cell carcinoma: After observing that IL-6 increases PD-L2 expression in HNSCC cell lines, they proposed to study IL-6 inhibitors in the treatment of HNSCC with high expression of this interleukin, but to date, there are no clinical trials on this subject [18].